Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Tight junction | R-HSA-2134514 | map04530 | tiletamine | 26533 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | tiletamine | 26533 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | tiletamine | 26533 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | tiletamine | 26533 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | tiletamine | 26533 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | tiletamine | 26533 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | tiletamine | 26533 | drug-path |
| Type II diabetes mellitus | R-HSA-2127377 | map04930 | tiletamine | 26533 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | tiletamine | 26533 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | clemastine | 26987 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | clemastine | 26987 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | clemastine | 26987 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | ginkgolide A | 3735 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ginkgolide A | 3735 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | ginkgolide A | 3735 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | ginkgolide A | 3735 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | ginkgolide A | 3735 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | ginkgolide A | 3735 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | chenodeoxycholic acid | 457 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | chenodeoxycholic acid | 457 | drug-path |